Tag
Glenmark Pharmaceuticals Limited
2 articles
Glenmark's IGI Submits IND for ISB 2301 Cancer Drug
Ichnos Glenmark Innovation submitted an IND application to U.S. FDA for ISB 2301, a first-in-class multispecific immune cell activator targeting solid tumors.
The pentaspecific molecule targets three
Glenmark Launches Authorized Generic Axitinib Tablets
Glenmark Pharmaceuticals Inc., USA launched an authorized generic version of INLYTA® (axitinib) tablets in 1 mg and 5 mg strengths.
The U.S. annual sales for INLYTA® Tablets were approximately $538.4